ZCM
DGX icon

Zebra Capital Management’s Quest Diagnostics DGX Stock Holding History

Zebra Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,969
Closed -$803K – 227
2014
Q4 		$803K Sell
11,969
-133
-1% -$8.39K 0.31% 158
2014
Q3 		$734K Buy
12,102
+305
+3% +$18.8K 0.29% 173
2014
Q2 		$692K Buy
11,797
+3,082
+35% +$180K 0.27% 181
2014
Q1 		$505K Buy
+8,715
New +$467K 0.21% 172

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Zebra Capital Management's DGX Position: Q1 2015 in Review

Zebra Capital Management sold out of Quest Diagnostics (DGX) in Q1 2015, closing a stake of 11,969 shares — an estimated $803K sold.

Zebra Capital Management first reported a position in DGX in Q1 2014 and held it in 4 quarters. The position peaked at $803K in Q4 2014. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

  • Zebra Capital Management reported no remaining Quest Diagnostics position as of Q1 2015 after selling out during the quarter.
  • Zebra Capital Management sold 11,969 Quest Diagnostics shares in Q1 2015, an estimated $803K.
  • Zebra Capital Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 4 quarters.
  • Zebra Capital Management's Quest Diagnostics position peaked at $803K in Q4 2014.
  • 553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Zebra Capital Management's 13F filing for Q1 2015, filed 30 Apr 2015.